News & Analysis as of September 25, 2024

America Invents Act › Abuse of Process

+ Follow

The Leahy-Smith America Invents Act is a United States federal statute enacted in 2011 aimed at simplifying the U.S. patent system and allowing inventions to be brough to market sooner. The AIA makes significant changes to the patent system, including changing from a first-to-invent scheme to a first-to-file scheme, eliminating interference proceedings and developing post-grant opposition. less -

OpenSky – Director Finds Abuse Of Process

Jones Day on 10/21/2022

In OpenSky Industries, LLC v. VLSI Technology LLC, Under Secretary of Commerce for Intellectual Property, Katherine Vidal, issued a precedential decision regarding OpenSky’s violation of the Director’s express order and...more

Several hedge fund-linked IPR Petitions Instituted: PTAB Finds No Abuse of Process

Foley & Lardner LLP on 1/7/2016

Following a string of denials, the PTAB has recently instituted IPR against several pharmaceutical patents where the petitions were filed by entities linked to hedge funds. Prior to these recent institution decisions, there...more

MoFo IP Newsletter - October 2015

Morrison & Foerster LLP on 10/8/2015

The Survey Says: Tiffany Is Not Generic for A Ring Setting - Last month, the Southern District of New York granted summary judgment to Tiffany & Co. on its trademark infringement claim against Costco Wholesale...more

PTAB Refuses To Sanction Kyle Bass

Foley & Lardner LLP on 9/28/2015

Many pharmaceutical companies have complained about the IPR petitions filed by Kyle Bass and the Coalition for Affordable Drugs against Orange Book-listed patents covering approved pharmaceutical products, but Celgene Corp....more

Celgene’s Pending Sanctions Motions against Kyle Bass’s Hedge Fund

Morrison & Foerster LLP on 8/26/2015

The Patent Trial and Appeals Board (PTAB) previously authorized Celgene Corporation (“Celgene”) to move for sanctions against the Coalition for Affordable Drugs (“Coalition”), an entity affiliated with a Kyle Bass hedge fund...more

PTAB Denies Inter Partes Review Petitions Against Two Acorda Patents

McDonnell Boehnen Hulbert & Berghoff LLP on 8/25/2015

One of the statistics gleaned from Director Michelle Lee's recent blog on the post-issuance review provisions of the America Invents Act is that only 42% of inter partes review petitions have been granted over the past three...more

Will New PTAB Rules Impact IPRs Filed By Kyle Bass Hedge Fund?

Foley & Lardner LLP on 8/24/2015

On August 19th, the USPTO released a new set of proposed rules related to post-grant proceedings before the Patent Trial and Appeal Board (PTAB). Among the many offered rules was the addition of a “Rule 11-type certification”...more

Bass Opposes Sanctions and Defends His Actions at the PTAB

Fish & Richardson on 8/12/2015

On July 28, 2015, Celgene filed a motion for sanctions in IPR Nos. 2015-01092 and 2015-01103, proceedings challenging the validity of Celgene patents covering Thalomid®, Revlimid® and Pomalyst®. Celgene specifically...more

PTAB to Consider Motion for “Abuse of Process” Sanctions Against Kyle Bass Hedge Fund IPR Petition

Morrison & Foerster LLP on 6/16/2015

In a recent order, the Patent Trial and Appeals Board (PTAB) indicated that it will consider a motion for sanctions based on a claim of “abuse of process” in Inter Partes Review (IPR) proceedings filed by the Coalition for...more

9 Results

View per page

Page: of 1

America Invents Act › Abuse of Process

"My best business intelligence, in one easy email…"